Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Oct 13.
Published in final edited form as: Biopolymers. 2008 May;89(5):479–485. doi: 10.1002/bip.20890

From Helix–Coil Transitions to Protein Folding

Harold A Scheraga 1
Editor: Lila Gierasch
PMCID: PMC2760957  NIHMSID: NIHMS147762  PMID: 18008324

Abstract

An evolution of procedures to simulate protein structure and folding pathways is described. From an initial focus on the helix–coil transition and on hydrogen-bonding and hydrophobic interactions, our original attempts to determine protein structure and folding pathways were based on an experimental approach. Experiments on the oxidative folding of reduced bovine pancreatic ribonuclease A (RNase A) led to a mechanism by which the molecule folded to the native structure by a minimum of four different pathways. The experiments with RNase A were followed by development of a molecular mechanics approach, first, making use of global optimization procedures and then with molecular dynamics (MD), evolving from an all-atom to a united-residue model. This hierarchical MD approach facilitated probing of the folding trajectory to longer time scales than with all-atom MD, and hence led to the determination of complete folding trajectories, thus far for a protein containing as many as 75 amino acid residues. With increasing refinement of the computational procedures, the computed results are coming closer to experimental observations, providing an understanding as to how physics directs the folding process.

Keywords: helix–coil transition, polyamino acids, collagen

INTRODUCTION

After Pauling discovered the α-helix and the β-sheet,1 it was natural to assume that an understanding of the interactions that lead to these conformations could be gained by studying the changes in conformation between these regular structures and the unfolded, statistical-coil form. This led to a flurry of both experimental2-4 and theoretical5-8 activity to consider, primarily, the helix–coil transition, with a later similar theoretical treatment of the transition between an antiparallel β-sheet and the statistical coil.9

Elkan Blout played a very important role in the experimental studies of the helix–coil transition by developing methods to synthesize high-molecular-weight poly-α-amino acids,2,10-16 to study their properties, including the helix–coil transition,17-21 with optical rotation,22-29 circular dichroism,30,31 and infrared spectroscopy,32-38 and by demonstrating the biological properties of some of these homopolymers, e.g., their antigenicity.39 He also developed synthetic methods to study polyproline and models of the triple helix of collagen,31,40-48 including the triple helix-to-coil transition,49 and demonstrated the presence of cis peptide bonds preceding proline.50 Elkan was thus a leader among several other eminent scientists in studies of the conformational properties of poly-α-amino acids.

The theoretical work on the helix–coil transition was based on the one-dimensional Ising model, for which a matrix treatment was used to formulate the partition function to calculate the thermodynamic properties of the transitions in homopolyamino acids. This theoretical approach was extended to treat copolymers, in addition to the original focus on homopolymers of amino acids, and thereby to acquire information about the tendencies of each of the 20 naturally occurring amino acids to take on the helix conformation at a given temperature.51 Aside from this application, however, it was soon realized that the helix–coil transition is not a good model for conformational changes in globular proteins, because the one-dimensional Ising model does not capture the cooperative features, embodied in the interplay between short- and long-range interactions, of the folding/unfolding transition of globular proteins.52-57

The parallel development of molecular mechanics (MM) was designed to overcome the failure of the one-dimensional Ising model to treat the protein folding problem. During the development of MM, the helix–coil transition was treated as one example58-62 of the valid application of the developing MM methodology. This article describes our early experimental approach, which then evolved into a theoretical approach to determine protein structure and protein-folding pathways. The experimental approach focused on bovine pancreatic ribonuclease A (RNase A), and the theoretical approach evolved from some early applications of MM to treat the properties of the α-helix, and the extension of MM methodology to treat conformational changes in globular proteins, i.e., the protein-folding problem.

EARLY STUDIES OF HELIX–COIL TRANSITIONS

The early statistical mechanical treatment of the helix–coil transition is summarized in a book that provided the various theoretical approaches and also reprinted the seminal papers in which these approaches were described.63 The factors relating to the question of a phase transition in polyamino acids64 and polynucleotides,65 the kinetics of the helix–coil transition in polyamino acids,66-68 and the role of hydrophobic interactions between nonpolar side chains in stabilizing α-helices69,70 received extensive early consideration.

Early MM studies were carried out to assess the factors stabilizing α-helices,71,72 and determining the relative preferences for left- and right-handedness73 in the α-helical forms of polyamino acids. With verification by experiment,74 the MM method was extended to treat both the helical and coil forms, and hence the helix–coil transition in polyamino acids.58-62 These studies were the forerunner for the application of MM to nonregular linear75 and cyclic76 oligopeptides, and fibrous77,78 and globular79-82 proteins.

EARLY CONSIDERATION OF INTERRESIDUE INTERACTIONS, AND MOTIVATION FOR DEVELOPMENT AND APPLICATIONS OF MM

While proteins were known to be copolymers of amino acids linked by peptide bonds, it was the determination of the amino acid sequence of insulin by Sanger83 that established that such copolymers are unbranched, and consist of unique amino acid sequences. At about the same time, Pauling proposed the α-helix and β-sheet conformations by relying heavily on the presence of hydrogen bonds between the NH and CO groups of the backbone of the polypeptide chain.1

Recognizing that the unique properties of proteins also depend on the interactions among their side chains,84 we investigated the effect of hydrogen bonds on the acid-base equilibria (pKs) of ionizable side-chain groups85 and on limited proteolysis.86 For example, if a tyrosyl-OH group is hydrogen-bonded to a glutamyl-COO group, then the pK of the tyrosyl group will be raised, and that of the COOH group will be lowered by the free energy of formation of the hydrogen bond.85 Therefore, identification of such “abnormal” pK's provides a clue as to the existence of such a hydrogen bond. In addition, the free energy for disrupting such a hydrogen bond will have to be paid in hydrolyzing the peptide group of the backbone whose side-chain hydrogen bonds must be broken to liberate the peptide fragment.86 Therefore, in contrast to the hydrolysis of, say, a simple dipeptide, which thermodynamically goes to completion, the hydrolysis of a peptide group when the side chain is hydrogen-bonded will not go to completion; i.e., as demonstrated in the thrombin-catalyzed hydrolysis of peptides from fibrinogen,87,88 such a limited hydrolytic reaction catalyzed by a proteolytic enzyme can be involved in a reversible equilibrium. In other words, a proteolytic enzyme can catalyze the formation of a peptide bond, because the hydrogen bonds between the fragment and the rest of the protein provide favorable thermodynamics for peptide-bond synthesis.86 Supporting experimental evidence for this view of limited protolysis86 was also provided by Seifter et al.89

This model of peptide-bond synthesis takes on added significance in considering the role of the ribosome in the synthesis of peptide bonds.90 Gindulyte et al.90 carried out quantum mechanical calculations on a group of 50 atoms chosen to represent the formation of the transition state (TS) during peptide-bond formation on the ribosome. They computed the activation energy for the process, and found that the hydrogen bonds that are formed between the 3′ end of the A-site tRNA and atoms of the ribosomal environment, while translocating into the P-site, lowered the activation energy for formation of the TS. We may regard such hydrogen bonds as also providing the free energy of equilibrium stabilization of the newly formed peptide bond.

Hydrophobic interactions91,92 can provide further stabilization of hydrogen bonds. For example, hydrophobic interactions, in which, say, a leucine side chain interacts with the nonpolar neck of a hydrogen-bonded glutamyl residue (as illustrated in Fig. 1 of Ref. 93) can strengthen such a lysyl · · · glutamyl hydrogen bond. The consequence of the earlier considerations is that hydrogen bonds can be located by potentiometric titrations that identify ionizable groups with abnormal pKs. With associated physical–chemical and biochemical studies94 to identify hydrogen-bonded pairs, such hydrogen bonds provide distance constraints on how the backbone may fold.

The foregoing provided the rationale to obtain distance constraints94 to determine the folded structure of a protein before the advent of X-ray or NMR methods to determine protein structures. In particular, 3 out of 6 tyrosyl side chains, and 3 out of 11 side-chain carboxyl groups, of RNase A were found to have abnormal pKs, which suggested the possible existence of three hydrogen bonds. In a series of chemical modifications (before the advent of recombinant DNA techniques) and physical–chemical and biochemical studies, three tyrosyl–aspartyl interactions (out of 19,800 ways to specifically pair 3 out of 6 tyrosyl side chains with 3 out of 11 side-chain carboxyl groups) were identified,94 namely Tyr25 · · · Asp14, Tyr 92 · · · Asp 38, and Tyr 97 · · · Asp83. These interactions were confirmed by the subsequent determination of the crystal structure of RNase A.95

These three Tyr · · · Asp interactions, plus the location of four disulfide bonds in RNase A, and the suggestion96,97 that His12, His119, and Lys41 are in the active site of this enzyme, constituted distance constraints that motivated the development of computational methodology98 to calculate the three-dimensional structure of the protein, by making use of these distance constraints in the minimization of the empirical conformational energy of the protein. Without introducing the conformational energy and minimizing its energy, this limited number of distance constraints is not sufficient to determine the backbone structure. In fact, ~80 distance constraints, with half of them between residues i and j in the range of 5 ≤ |i – j| ≤ 20 and the other half with |i – j| ≥ 21, would be required99 in order to obtain the structure of a 57-residue protein with an RMSD < 2 Å with respect to the native structure if these distances are known exactly. If the distances in these two ranges are known only within an error no greater than ~2 Å, then more than ~150 such distances are required. Additional information is available99 about how the distributions of |i – j| distances and through-space distances dij affect the RMSD. Hence, the evolution of computational methodology in our laboratory proceeded in two different directions making use of (1) knowledge-based information (distance constraints, homology modeling, etc.) together with an empirical potential-energy function and (2) a physics-based potential-energy function without reliance on knowledge-based information.

EXPERIMENTAL DETERMINATION OF FOLDING PATHWAYS

When Anfinsen identified spontaneous protein folding and introduced the thermodynamic hypothesis for a theoretical approach,100 we expanded our interest in determining protein structure to also determine folding pathways (first by experiment and later by theoretical methods).

Our initial experimental work was carried out with insulin, the only protein whose amino acid sequence was known83 at the time. However, experimental difficulties arose in the attempt to locate hydrogen bonds by potentiometric titration to determine pKs, because insulin is largely insoluble at neutral pH. But, as soon as the amino sequence of lysozyme was determined, our efforts turned to this protein which is soluble over the pH range of interest. However, lysozyme also presented experimental problems because of its relatively high tryptophan content. To locate hydrogen bonds by observing abnormal pKs of ionizable side-chain groups, it was necessary to carry out chemical modification and determine the amino acid composition of proteolytically obtained fragments. But, analysis for tryptophan was very difficult before the later development of improved methods for determining amino acid composition. Finally, with the availability of the amino acid sequence of RNase A, which is water-soluble and contains no tryptophan, it was possible to determine the kinetics and thermodynamics in the oxidative folding of RNase A, using either glutathione101 or dithiothreitol102104 as the oxidizing agent.

With dithiothreitol as the redox reagent, the following mechanism was deduced for the oxidative folding of RNase A: graphic file with name nihms-147762-f0001.jpg where R is the reduced protein, and 1S–4S are ensembles of one-, two-, three- and four-disulfide species, respectively (with the subscript U indicating that they are essentially unfolded species). The 1S–4S species are involved in a pre-equilibrium (quasi-steady-state condition). In the rate-determining step, the 3SU ensemble reshuffles by SH/SS interchange along two different pathways (in the approximate ratio 78:18) to form native-like des [40 – 95]N and des [65 – 72]N, respectively, both of which go rapidly to the native form. The remaining ~5% of the protein goes through two separate pathways, which could be detected only by mutating the Cys40, Cys95 and Cys65, Cys72 residues, respectively, to prevent formation of the corresponding disulfide bonds.105,106 The rate-determining step in the oxidative folding of each of these two mutants involves oxidation from the 2SU ensemble to the native form, rather than SH/SS interchange, as illustrated in the following scheme: graphic file with name nihms-147762-f0002.jpg

Thus, these experiments identified a minimum of four different pathways for the oxidative folding of wild-type RNase A.

In the initial folding stages, i.e., up to formation of the 1S ensemble of wild-type RNase A, 40% of the 28 theoretically possible 1S forms have the 65–72 disulfide bond,107 which persists to an even greater extent in the formation of the 2S ensemble.108 The following scheme illustrates some details of the folding pathways of wild-type RNase A: graphic file with name nihms-147762-f0003.jpg

The preference of the 4:1 ratio for the native 65–72 disulfide bond relative to the non-native 58–65 disulfide bond is the same in the 1S folding stage of both the native protein and of an isolated 58–72 fragment.109,110 Since both possible loops, 58–65 and 65–72, have the same number of residues and, hence, involve the same entropy of loop closure, this 4:1 ratio indicates that specific local interactions lead to the preference for formation of the 65–72 loop; such preferential interactions in this loop have been identified by NMR111 and MM112 computations.

COMPUTATIONS OF POLYPEPTIDE AND PROTEIN STRUCTURE WITH AN ALL-ATOM FORCE FIELD

The experimental work described earlier led to the development of MM98,113 to compute protein structure. Using an all-atom representation of the polypeptide chain and an empirical potential-energy function, Empirical Conformational Energy Program for Peptides (ECEPP),114 together with a variety of procedures for global optimization of the potential energy,115 the low-energy (global-minimum) structures of various α-helices,71-73 several linear75 and cyclic76 peptides, and fibrous proteins,77,78 were computed. As an example, one of these global optimization procedures, Electrostatically Driven Monte Carlo (EDMC),116 together with an implicit hydration model, was used79 in four simulations of the 46-residue three-helix bundle, protein A, providing structures within an RMSD of ~4 Å from the known native structure. This was the largest protein whose all-atom structure had been computed at the time, and the calculation was carried out in 11 days with 60 processors of a Beowulf-type cluster. By contrast, a single trajectory on a smaller, 36-residue protein, the villin headpiece, simulated by molecular dynamics (MD),117 required 4 months on a Cray computer. The villin headpiece was subsequently simulated80 with the EDMC procedure.

COMPUTATION OF FOLDING PATHWAYS WITH AN ALL-ATOM FORCE FIELD

The folding pathway of protein A118 from an initial unfolded state i to a final folded state f was computed by use of a procedure, involving a stochastic difference equation (SDE), developed by Elber et al.119 Both states i and f must be known in order to compute the pathways from i to f with the SDE procedure. The folded state f, of course, is either an X-ray or NMR structure of the protein. But the initial state i is not a single structure, but rather an ensemble of unfolded structures. Therefore, 130 representative structures were generated by MD; each of them was treated as an initial state i, and then all 130 trajectories were averaged.

In the SDE procedure, the action, S, defined as if[2(EU)]12dl, is required to remain stationary along the trajectory length l from i to f, where E is the total energy, and U is the potential energy. From the computed results, it appeared that the C-terminal helix folded first, followed by the N-terminal helix, and then the middle helix. Contrary to expectations, it was found118 that the radius of gyration did not decrease significantly until about halfway through the trajectory, i.e., an initial “hydrophobic collapse” was not observed. We have recently found120 that the sequence of folding events is sensitive to the external conditions (temperature, friction, and random forces).

COMPUTATION OF STRUCTURE AND FOLDING PATHWAYS BY A HIERARCHIAL PROCEDURE

Although an all-atom representation of the polypeptide chain could be used to compute the structure79 and folding pathway118 of the 46-residue protein A, it has not yet been possible to compute protein structures and folding pathways for proteins containing 100–200 residues with the all-atom representation. We have therefore developed a hierarchical approach in which the all-atom representation is initially replaced by a united-residue (UNRES) model,121 and the search of the UNRES potential energy is carried out with a conformational space annealing (CSA) method.122 The motivation of this search is to locate the region of the global minimum; then the results of the UNRES search are converted to an all-atom representation,123,124 and the search is continued in this region with the EDMC procedure.

The UNRES model is obtained by averaging over all “unimportant” fast degrees of freedom, thereby reducing the number of force centers and the number of degrees of freedom, and rendering the search procedure feasible for large proteins. The CSA search procedure starts with a representative set of local minima in the multidimensional conformation energy space, and reduces their distribution (to the region of the global minimum) by selected moves in what is essentially a genetic algorithm. The results have been subjected to blind tests82 in successive (critical assessment of protein structure prediction procedures, CASP).

The predicted results have been sufficiently encouraging to motivate carrying out MD calculations with the UNRES model rather than with an all-atom one. Because all-atom MD trajectories require femtosecond moves to change conformation and, hence, do not reach the millisecond-to-second time-scale for folding all but the very fast-folding proteins, MD has not been successful in folding all-atom structures. However, because the fast degrees of freedom are averaged out in UNRES, it seemed possible that MD with UNRES might be able to simulate protein folding. Therefore, the mathematics for a Langevin-equation approach was formulated, and solved with a stochastic velocity Verlet algorithm.125,126 This approach was successful in folding largely α-helical single-chain81 and two-chain127 proteins, one containing as many as 75 residues, and in simulating folding kinetics.128 To be able to treat α+β and β proteins, it was found to be necessary to introduce entropic effects.129

CONCLUSIONS

Motivated originally by the experimental acquisition of distance constraints in RNase A by physical–chemical and biochemical procedures, a MM approach was developed to compute the three-dimensional structures of proteins. Later, in order to focus on the physics of inter-residue interactions in determining protein structures, reliance on knowledge-based information, such as experimental distance constraints, was abandoned in favor of the use of only the potential energy. Early investigations were carried out by global optimization of an all-atom representation of the potential energy but, in order to treat large protein structures, this approach evolved into a hierarchy procedure based on a UNRES representation of the potential energy. Subsequently, UNRES was used to compute not only protein structure but also folding pathways by means of the Langevin equation. Further, improvement129 of the force field by including entropic effects and focusing on reproduction of thermodynamic properties, such as heat capacity, has led to improved predictions of protein structure.

Acknowledgments

Contract grant sponsors: NIH and NSF

Footnotes

This article is dedicated to the memory of Elkan Blout, whose friendship and seminal experimental studies of biopolymers, including the helix–coil transition in polyamino acids, and models of collagen, are fondly remembered.

This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com

REFERENCES

  • 1.Pauling L, Corey RB, Branson HR. Proc Natl Acad Sci USA. 1951;37:205–211. doi: 10.1073/pnas.37.4.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Blout ER, Karlson RH. J Am Chem Soc. 1956;78:941–946. [Google Scholar]
  • 3.Doty P, Bradbury JH, Holtzer AM. J Am Chem Soc. 1956;78:947–954. [Google Scholar]
  • 4.Katchalski E, Sela M. Adv Protein Chem. 1958;13:243–492. doi: 10.1016/s0065-3233(08)60600-2. [DOI] [PubMed] [Google Scholar]
  • 5.Schellman JA. Compt Rend Trav Lab Carlsberg Sér Chim. 1955;29:223–259. [PubMed] [Google Scholar]
  • 6.Zimm BH, Bragg JK. J Chem Phys. 1959;31:526–535. [Google Scholar]
  • 7.Lifson S, Roig A. J Chem Phys. 1961;34:1963–1971. [Google Scholar]
  • 8.Poland DC, Scheraga HA. J Chem Phys. 1965;43:2071–2074. doi: 10.1063/1.1697076. erratum: J Chem Phys 1965, 43, 3774.
  • 9.Mattice WL, Scheraga HA. Biopolymers. 1984;23:1701–1724. doi: 10.1002/bip.360230907. [DOI] [PubMed] [Google Scholar]
  • 10.Blout ER, Karlson RH, Doty P, Hargitay B. J Am Chem Soc. 1954;76:4492–4493. [Google Scholar]
  • 11.Blout ER, Idelson M. J Am Chem Soc. 1956;78:3857–3858. [Google Scholar]
  • 12.Blout ER, Idelson M. J Am Chem Soc. 1958;80:4909–4913. [Google Scholar]
  • 13.Idelson M, Blout ER. J Am Chem Soc. 1958;80:2387–2393. [Google Scholar]
  • 14.Blout ER, DesRoches ME. J Am Chem Soc. 1959;81:370–372. [Google Scholar]
  • 15.Fasman GD, Blout ER. J Am Chem Soc. 1960;82:2262–2267. [Google Scholar]
  • 16.Fasman GD, Idelson M, Blout ER. J Am Chem Soc. 1961;83:7099–712. [Google Scholar]
  • 17.Doty P, Holtzer AM, Bradbury JH, Blout ER. J Am Chem Soc. 1954;76:4492–4493. [Google Scholar]
  • 18.Blout ER, Idelson M. J Am Chem Soc. 1956;78:497–498. [Google Scholar]
  • 19.Doty P, Wada A, Yang JT, Blout ER. J Polym Sci. 1957;23:851–861. [Google Scholar]
  • 20.Blout ER, Lenormant H. Nature. 1957;179:960–963. doi: 10.1038/179960a0. [DOI] [PubMed] [Google Scholar]
  • 21.Tomita K, Rich A, de Lozé C, Blout ER. J Mol Biol. 1962;4:83–92. doi: 10.1016/s0022-2836(62)80040-0. [DOI] [PubMed] [Google Scholar]
  • 22.Blout ER, Doty P, Yang JT. J Am Chem Soc. 1957;79:749–750. [Google Scholar]
  • 23.Blout ER, Karlson RH. J Am Chem Soc. 1958;80:1259–1260. [Google Scholar]
  • 24.Idelson M, Blout ER. J Am Chem Soc. 1958;80:4631–4634. [Google Scholar]
  • 25.Blout ER. Proceedings of the fourth International Congress of Biochemistry; Pergamon: London. 1959. pp. 37–41. [Google Scholar]
  • 26.Karlson RH, Norland KS, Fasman GD, Blout ER. J Am Chem Soc. 1960;82:2268–2275. [Google Scholar]
  • 27.Shechter E, Blout ER. Proc Natl Acad Sci USA. 1964;51:695–702. doi: 10.1073/pnas.51.4.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Shechter E, Blout ER. Proc Natl Acad Sci USA. 1964;51:794–800. doi: 10.1073/pnas.51.5.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shechter E, Carver JP, Blout ER. Proc Natl Acad Sci USA. 1964;51:1029–1036. doi: 10.1073/pnas.51.6.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Simmons NS, Cohen C, Szent-Gyorgyi AG, Wetlaufer DB, Blout ER. J Am Chem Soc. 1961;83:4766–4769. [Google Scholar]
  • 31.Blout ER, Carver JP, Gross J. J Am Chem Soc. 1963;85:644–645. [Google Scholar]
  • 32.Blout ER, Asadourian A. J Am Chem Soc. 1956;78:955–961. [Google Scholar]
  • 33.Idelson M, Blout ER. J Am Chem Soc. 1957;79:3948–3955. [Google Scholar]
  • 34.Blout ER. Ann NY Acad Sci. 1957;69:84–93. doi: 10.1111/j.1749-6632.1957.tb49651.x. [DOI] [PubMed] [Google Scholar]
  • 35.Bird GR, Parrish M, Jr., Blout ER. Rev Sci Instr. 1958;29:305–309. [Google Scholar]
  • 36.Bird GR, Blout ER. J Am Chem Soc. 1959;81:2499–2503. [Google Scholar]
  • 37.Miyazawa T, Blout ER. J Am Chem Soc. 1961;83:712–719. [Google Scholar]
  • 38.Blout ER, de Lozé C, Asadourian A. J Am Chem Soc. 1961;83:1895–1900. [Google Scholar]
  • 39.Maurer PH, Subrahmanyam D, Kathchalski E, Blout ER. J Immunol. 1959;83:193–197. [Google Scholar]
  • 40.Blout ER, Fasman GD. Recent Advances in Gelatin and Glue Research. Pergamon; London: 1957. pp. 122–130. [Google Scholar]
  • 41.Fasman GD, Blout ER. Biopolymers. 1963;1:3–14. [Google Scholar]
  • 42.Oriel PJ, Blout ER. J Am Chem Soc. 1966;88:2041–2045. [Google Scholar]
  • 43.Carver JP, Blout ER. Treatise on Collagen. Vol. 1. Academic Press; New York: 1967. pp. 441–526. [Google Scholar]
  • 44.Ramachandran GN, Doyle BB, Blout ER. Biopolymers. 1968;6:1771–1775. doi: 10.1002/bip.1968.360061213. [DOI] [PubMed] [Google Scholar]
  • 45.Brown FR, III, Carver JP, Blout ER. J Mol Biol. 1969;39:307–313. doi: 10.1016/0022-2836(69)90319-2. [DOI] [PubMed] [Google Scholar]
  • 46.Kivirikko KI, Prockop DJ, Lorenzi GP, Blout ER. J Biol Chem. 1969;244:2755–2760. [PubMed] [Google Scholar]
  • 47.Lorenzi GP, Doyle BB, Blout ER. Biochemistry. 1971;10:3046–3051. doi: 10.1021/bi00792a010. [DOI] [PubMed] [Google Scholar]
  • 48.Doyle BB, Traub W, Lorenzi GP, Blout ER. Biochemistry. 1971;10:3052–3060. doi: 10.1021/bi00792a011. [DOI] [PubMed] [Google Scholar]
  • 49.Brown FR, III, Hopfinger AJ, Blout ER. J Mol Biol. 1972;63:101–115. doi: 10.1016/0022-2836(72)90524-4. [DOI] [PubMed] [Google Scholar]
  • 50.Deber CM, Bovey FA, Carver JP, Blout ER. J Am Chem Soc. 1970;92:6191–6198. doi: 10.1021/ja00724a016. [DOI] [PubMed] [Google Scholar]
  • 51.Scheraga HA, Vila JA, Ripoll DR. Biophys Chem. 2002;101–102:255–265. doi: 10.1016/s0301-4622(02)00175-8. [DOI] [PubMed] [Google Scholar]
  • 52.Hao MH, Scheraga HA. J Phys Chem. 1994;98:4940–4948. [Google Scholar]
  • 53.Hao MH, Scheraga HA. J Phys Chem. 1994;98:9882–9893. [Google Scholar]
  • 54.Hao MH, Scheraga HA. J Chem Phys. 1995;102:1334–1348. [Google Scholar]
  • 55.Hao MH, Scheraga HA. J Chem Phys. 1997;107:8089–8102. [Google Scholar]
  • 56.Hao MH, Scheraga HA. J Mol Biol. 1998;277:973–983. doi: 10.1006/jmbi.1998.1658. [DOI] [PubMed] [Google Scholar]
  • 57.Hao MH, Scheraga HA. Acc Chem Res. 1998;31:433–440. [Google Scholar]
  • 58.Go N, Go M, Scheraga HA. Proc Natl Acad Sci USA. 1968;59:1030–1037. doi: 10.1073/pnas.59.4.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Go M, Go N, Scheraga HA. J Chem Phys. 1970;52:2060–2079. doi: 10.1063/1.1673260. [DOI] [PubMed] [Google Scholar]
  • 60.Go M, Go N, Scheraga HA. J Chem Phys. 1971;54:4489–4503. [Google Scholar]
  • 61.Go M, Hesselink FT, Go N, Scheraga HA. Macromolecules. 1974;7:459–467. doi: 10.1021/ma60040a013. [DOI] [PubMed] [Google Scholar]
  • 62.Go M, Scheraga HA. Biopolymers. 1984;23:1961–1977. doi: 10.1002/bip.360231012. [DOI] [PubMed] [Google Scholar]
  • 63.Poland D, Scheraga HA. Theory of Helix-Coil Transitions in Biopolymers. Academic Press; New York: 1970. [Google Scholar]
  • 64.Poland D, Scheraga HA. J Chem Phys. 1966;45:1456–1463. doi: 10.1063/1.1727785. [DOI] [PubMed] [Google Scholar]
  • 65.Poland D, Scheraga HA. J Chem Phys. 1966;45:1464–1469. doi: 10.1063/1.1727786. [DOI] [PubMed] [Google Scholar]
  • 66.Schwarz G. J Mol Biol. 1965;11:64–77. doi: 10.1016/s0022-2836(65)80171-1. [DOI] [PubMed] [Google Scholar]
  • 67.McQuarrie DA, McTague JP, Reiss H. Biopolymers. 1965;3:657–663. doi: 10.1002/bip.360030605. [DOI] [PubMed] [Google Scholar]
  • 68.Poland D, Scheraga HA. J Chem Phys. 1966;45:2071–2090. doi: 10.1063/1.1727893. [DOI] [PubMed] [Google Scholar]
  • 69.Poland DC, Scheraga HA. Biopolymers. 1965;3:315–334. [Google Scholar]
  • 70.Poland DC, Scheraga HA. Biopolymers. 1965;3:335–355. [Google Scholar]
  • 71.Ooi T, Scott RA, Vanderkooi G, Scheraga HA. J Chem Phys. 1967;46:4410–4426. doi: 10.1063/1.1840561. [DOI] [PubMed] [Google Scholar]
  • 72.Yan JF, Vanderkooi G, Scheraga HA. J Chem Phys. 1968;49:2713–2726. doi: 10.1063/1.1670476. [DOI] [PubMed] [Google Scholar]
  • 73.Yan JF, Momany FA, Scheraga HA. J Am Chem Soc. 1970;92:1109–1115. [Google Scholar]
  • 74.Erenrich EH, Andreatta RH, Scheraga HA. J Am Chem Soc. 1970;92:1116–1119. [Google Scholar]
  • 75.Li Z, Scheraga HA. J Mol Struct (Theochem) 1988;179:333–352. [Google Scholar]
  • 76.Dygert M, Go N, Scheraga HA. Macromolecules. 1975;8:750–761. doi: 10.1021/ma60048a016. [DOI] [PubMed] [Google Scholar]
  • 77.Miller MH, Scheraga HA. J Polym Sci: Polym Symp. 1976;54:171–200. [Google Scholar]
  • 78.Fossey SA, Némethy G, Gibson KD, Scheraga HA. Biopolymers. 1991;31:1529–1541. doi: 10.1002/bip.360311309. [DOI] [PubMed] [Google Scholar]
  • 79.Vila JA, Ripoll DR, Scheraga HA. Proc Natl Acad Sci USA. 2003;100:14812–14816. doi: 10.1073/pnas.2436463100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Ripoll DR, Vila JA, Scheraga HA. J Mol Biol. 2004;339:915–925. doi: 10.1016/j.jmb.2004.04.002. [DOI] [PubMed] [Google Scholar]
  • 81.Liwo A, Khalili M, Scheraga HA. Proc Natl Acad Sci USA. 2005;102:2362–2367. doi: 10.1073/pnas.0408885102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Oldziej S, Czaplewski C, Liwo A, Chinchio M, Nanias M, Vila JA, Khalili M, Arnautova YA, Jagielska A, Makowski M, Schafroth HD, Kazmierkiewicz R, Ripoll DR, Pillardy J, Saunders JA, Kang YK, Gibson KD, Scheraga HA. Proc Natl Acad Sci USA. 2005;102:7547–7552. doi: 10.1073/pnas.0502655102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Sanger F. In: Currents in Biochemical Research. Green DE, editor. Interscience; New York: 1956. pp. 434–459. [Google Scholar]
  • 84.Neurath H, Greenstein JP, Putnam FW, Erickson JO. Chem Rev. 1944;34:157–265. [Google Scholar]
  • 85.Laskowski M, Jr., Scheraga HA. J Am Chem Soc. 1954;76:6305–6319. [Google Scholar]
  • 86.Laskowski M, Jr., Scheraga HA. J Am Chem Soc. 1956;78:5793–5798. [Google Scholar]
  • 87.Laskowski M, Jr., Donnelly TH, Van Tijn BA, Scheraga HA. J Biol Chem. 1956;222:815–821. [PubMed] [Google Scholar]
  • 88.Laskowski M, Jr., Ehrenpreis S, Donnelly TH, Scheraga HA. J Am Chem Soc. 1960;82:1340–1348. [Google Scholar]
  • 89.Seifter S, Gallop PM, Klein L, Meilman E. J Biol Chem. 1959;234:285–293. [PubMed] [Google Scholar]
  • 90.Gindulyte A, Bashan A, Agmon I, Massa L, Yonath A, Karle J. Proc Natl Acad Sci USA. 2006;130:13327–13332. doi: 10.1073/pnas.0606027103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Némethy G, Scheraga HA. J Phys Chem. 1962;66:1773–1789. [Google Scholar]
  • 92.Griffith JH, Scheraga HA. J Mol Struct. 2004;682:97–113. [Google Scholar]
  • 93.Némethy G, Steinberg IZ, Scheraga HA. Biopolymers. 1963;1:43–69. [Google Scholar]
  • 94.Scheraga HA. Fed Proc. 1967;26:1380–1387. [PubMed] [Google Scholar]
  • 95.Wlodawer A, Svensson LA, Sjölin L, Gillland GL. Biochemistry. 1988;27:2705–2717. doi: 10.1021/bi00408a010. [DOI] [PubMed] [Google Scholar]
  • 96.Hirs CHW, Halmann M, Kycia JH. In: Biological Structure and Function. Goodwin TW, Lindberg O, editors. Vol. 1. Academic Press; New York: 1961. pp. 41–57. [Google Scholar]
  • 97.Heinrikson L. J Biol Chem. 1966;241:1393–1405. [PubMed] [Google Scholar]
  • 98.Némethy G, Scheraga HA. Biopolymers. 1965;3:155–184. [Google Scholar]
  • 99.Wako H, Scheraga HA. Macromolecules. 1981;14:961–969. [Google Scholar]
  • 100.Anfinsen CB. Science. 1973;181:223–230. doi: 10.1126/science.181.4096.223. [DOI] [PubMed] [Google Scholar]
  • 101.Scheraga HA, Konishi Y, Ooi T. Adv Biophys. 1984;18:21–41. doi: 10.1016/0065-227x(84)90005-4. [DOI] [PubMed] [Google Scholar]
  • 102.Rothwarf DM, Li Y-J, Scheraga HA. Biochemistry. 1998;37:3760–3766. doi: 10.1021/bi972822n. [DOI] [PubMed] [Google Scholar]
  • 103.Rothwarf DM, Li Y-J, Scheraga HA. Biochemistry. 1998;37:3767–3776. doi: 10.1021/bi972823f. [DOI] [PubMed] [Google Scholar]
  • 104.Scheraga HA, Wedemeyer WJ, Welker E. In: Methods in Enzymology. Nicholson AW, editor. Vol. 341. Academic Press; San Diego: 2001. pp. 189–221. [DOI] [PubMed] [Google Scholar]
  • 105.Iwaoka M, Juminaga D, Scheraga HA. Biochemistry. 1998;37:4490–4501. doi: 10.1021/bi9725327. [DOI] [PubMed] [Google Scholar]
  • 106.Xu X, Scheraga HA. Biochemistry. 1998;37:7561–7571. doi: 10.1021/bi980086x. [DOI] [PubMed] [Google Scholar]
  • 107.Xu X, Rothwarf DM, Scheraga HA. Biochemistry. 1996;35:6406–6417. doi: 10.1021/bi960090d. [DOI] [PubMed] [Google Scholar]
  • 108.Volles MJ, Xu X, Scheraga HA. Biochemistry. 1999;38:7284–7293. doi: 10.1021/bi990570f. [DOI] [PubMed] [Google Scholar]
  • 109.Milburn PJ, Scheraga HA. J Protein Chem. 1988;7:377–398. doi: 10.1007/BF01024887. [DOI] [PubMed] [Google Scholar]
  • 110.Altmann KH, Scheraga HA. J Am Chem Soc. 1990;112:4926–4931. [Google Scholar]
  • 111.Talluri S, Falcomer CM, Scheraga HA. J Am Chem Soc. 1993;115:3041–3047. [Google Scholar]
  • 112.Carty RP, Pincus MR, Scheraga HA. Biochemistry. 2002;41:14815–14819. doi: 10.1021/bi0205350. [DOI] [PubMed] [Google Scholar]
  • 113.Scheraga HA. Adv Phys Org Chem. 1968;6:103–184. [Google Scholar]
  • 114.Némethy G, Gibson KD, Palmer KA, Yoon CN, Paterlini G, Zagari A, Rumsey S, Scheraga HA. J Phys Chem. 1992;96:6472–6484. [Google Scholar]
  • 115.Scheraga HA, Lee J, Pillardy J, Ye Y-J, Liwo A, Ripoll J. Glob Optimiz. 1999;15:235–260. [Google Scholar]
  • 116.Ripoll DR, Liwo A, Scheraga HA. Biopolymers. 1998;46:117–126. doi: 10.1002/(SICI)1097-0282(199808)46:2<117::AID-BIP6>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  • 117.Duan Y, Kollman PA. Science. 1998;283:740–744. doi: 10.1126/science.282.5389.740. [DOI] [PubMed] [Google Scholar]
  • 118.Ghosh A, Elber R, Scheraga HA. Proc Natl Acad Sci USA. 2002;99:10394–10398. doi: 10.1073/pnas.142288099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Elber R, Ghosh A, Cárdenas AA. Acc Chem Res. 2002;35:396–403. doi: 10.1021/ar010021d. [DOI] [PubMed] [Google Scholar]
  • 120.Jagielska A, Scheraga HA. J Comput Chem. 2007;28:1068–1082. doi: 10.1002/jcc.20631. [DOI] [PubMed] [Google Scholar]
  • 121.Liwo A, Czaplewski C, Pillardy J, Scheraga HA. J Chem Phys. 2001;115:2323–2347. [Google Scholar]
  • 122.Lee J, Scheraga HA, Rackovsky S. J Comput Chem. 1997;18:1222–1232. [Google Scholar]
  • 123.Kazmierkiewicz R, Liwo A, Scheraga HA. J Comput Chem. 2002;23:715–723. doi: 10.1002/jcc.10068. [DOI] [PubMed] [Google Scholar]
  • 124.Kazmierkiewicz R, Liwo A, Scheraga HA. Biophys Chem. 2003;100:261–280. doi: 10.1016/s0301-4622(02)00285-5. Erratum: Biophys Chem 2003, 106, 91.
  • 125.Khalili M, Liwo A, Rakowski F, Grochowski P, Scheraga HA. J Phys Chem B. 2005;109:13785–13797. doi: 10.1021/jp058008o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Khalili M, Liwo A, Jagielska A, Scheraga HA. J Phys Chem B. 2005;109:13798–13810. doi: 10.1021/jp058007w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Rojas AV, Liwo A, Scheraga HA. J Phys Chem B. 2007;111:293–309. doi: 10.1021/jp065810x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Khalili M, Liwo A, Scheraga HA. J Mol Biol. 2006;355:536–547. doi: 10.1016/j.jmb.2005.10.056. [DOI] [PubMed] [Google Scholar]
  • 129.Liwo A, Khalili M, Czaplewski C, Kalinowski S, Oldziej S, Wachucik K, Scheraga HA. J Phys Chem B. 2007;111:260–285. doi: 10.1021/jp065380a. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES